- Home
- CCRN vs FDMT Comparison
CCRN vs FDMT Comparison
Compare CCRN & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCRN | FDMT |
|---|---|---|
| Founded | 1986 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.7M | 449.6M |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CCRN | FDMT |
|---|---|---|
| Price | $13.20 | $11.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $14.15 | ★ $31.71 |
| AVG Volume (30 Days) | 503.9K | ★ 751.7K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $816,484,000.00 | $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.01 | $70.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $7.43 | $3.68 |
| 52 Week High | $14.98 | $12.34 |
Technical Indicators
Market Signals| Indicator | CCRN | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 74.20 | 68.10 |
| Support Level | $13.02 | $8.39 |
| Resistance Level | $13.23 | $11.85 |
| Average True Range (ATR) | 0.04 | 0.88 |
| MACD | -0.09 | 0.25 |
| Stochastic Oscillator | 78.13 | 87.40 |
Price Performance
Historical ComparisonAbout CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).